Chemical Biology of Protein Arginine Modifications in Epigenetic Regulation
暂无分享,去创建一个
[1] Xinbin Chen,et al. PRMT5 is required for cell-cycle progression and p53 tumor suppressor function , 2009, Nucleic acids research.
[2] C. Allis,et al. Histone hypercitrullination mediates chromatin decondensation and neutrophil extracellular trap formation , 2009, The Journal of cell biology.
[3] M. Surani,et al. Prmt5 is essential for early mouse development and acts in the cytoplasm to maintain ES cell pluripotency. , 2010, Genes & development.
[4] I. Newsham,et al. DAL-1/4.1B tumor suppressor interacts with protein arginine N-methyltransferase 3 (PRMT3) and inhibits its ability to methylate substrates in vitro and in vivo , 2004, Oncogene.
[5] P. Thompson,et al. Histone citrullination by protein arginine deiminase: is arginine methylation a green light or a roadblock? , 2006, ACS chemical biology.
[6] D. Hwang. Cation-π Interaction , 2013 .
[7] Xiaodong Cheng,et al. Surface-scanning mutational analysis of protein arginine methyltransferase 1: roles of specific amino acids in methyltransferase substrate specificity, oligomerization, and coactivator function. , 2007, Molecular endocrinology.
[8] D. Wagner,et al. VWF-mediated leukocyte recruitment with chromatin decondensation by PAD4 increases myocardial ischemia/reperfusion injury in mice. , 2014, Blood.
[9] Yuan Luo,et al. Activity-based protein profiling reagents for protein arginine deiminase 4 (PAD4): synthesis and in vitro evaluation of a fluorescently labeled probe. , 2006, Journal of the American Chemical Society.
[10] S. Pang,et al. Benzo[d]imidazole inhibitors of Coactivator Associated Arginine Methyltransferase 1 (CARM1)--Hit to Lead studies. , 2009, Bioorganic & medicinal chemistry letters.
[11] S. Clarke,et al. Mammalian Protein Arginine Methyltransferase 7 (PRMT7) Specifically Targets RXR Sites in Lysine- and Arginine-rich Regions* , 2013, The Journal of Biological Chemistry.
[12] A. Ishigami,et al. cDNA cloning, gene organization and expression analysis of human peptidylarginine deiminase type I. , 2003, The Biochemical journal.
[13] Remco Loos,et al. Citrullination regulates pluripotency and histone H1 binding to chromatin , 2014, Nature.
[14] J. Workman,et al. In and out: histone variant exchange in chromatin. , 2005, Trends in biochemical sciences.
[15] C. Werning. [Rheumatoid arthritis]. , 1983, Medizinische Monatsschrift fur Pharmazeuten.
[16] A. Kawada,et al. Comparative analysis of the mouse and human peptidylarginine deiminase gene clusters reveals highly conserved non-coding segments and a new human gene, PADI6. , 2004, Gene.
[17] A. Levine,et al. The p53 tumour suppressor gene , 1991, Nature.
[18] C. Ackerley,et al. Modifications of myelin basic protein in DM20 transgenic mice are similar to those in myelin basic protein from multiple sclerosis. , 1996, The Journal of clinical investigation.
[19] P. Thompson,et al. Purification of enzymatically inactive peptidylarginine deiminase type 6 from mouse ovary that reveals hexameric structure different from other dimeric isoforms , 2011 .
[20] M. Shirakawa,et al. Structural basis for recognition of H3K4 methylation status by the DNA methyltransferase 3A ATRX–DNMT3–DNMT3L domain , 2009, EMBO reports.
[21] A. Ishigami,et al. Human peptidylarginine deiminase type II: molecular cloning, gene organization, and expression in human skin. , 2002, Archives of biochemistry and biophysics.
[22] K. Mizuguchi,et al. The guanidino‐group modifying enzymes: Structural basis for their diversity and commonality , 2006, Proteins.
[23] T. Pawson,et al. Structural basis for recognition of arginine methylated Piwi proteins by the extended Tudor domain , 2010, Proceedings of the National Academy of Sciences.
[24] S. Coonrod,et al. Potential Role for Peptidylarginine Deiminase 2 (PAD2) in Citrullination of Canine Mammary Epithelial Cell Histones , 2010, PloS one.
[25] P. Thompson,et al. In situ generation of a bisubstrate analogue for protein arginine methyltransferase 1. , 2008, Journal of the American Chemical Society.
[26] M. Uffmann,et al. Very recent onset rheumatoid arthritis: clinical and serological patient characteristics associated with radiographic progression over the first years of disease. , 2006, Rheumatology.
[27] L. Pearl,et al. Insights into histone code syntax from structural and biochemical studies of CARM1 methyltransferase , 2007, The EMBO journal.
[28] P. Thompson,et al. The protein arginine deiminases: Structure, function, inhibition, and disease. , 2013, Biopolymers.
[29] X. Chang,et al. Expression of Peptidylarginine Deiminase Type 4 in Ovarian Tumors , 2010, International journal of biological sciences.
[30] Michael Sattler,et al. High-resolution X-ray and NMR structures of the SMN Tudor domain: conformational variation in the binding site for symmetrically dimethylated arginine residues. , 2003, Journal of molecular biology.
[31] E. Charpentier,et al. Structural basis for recognizing phosphoarginine and evolving residue-specific protein phosphatases in gram-positive bacteria. , 2013, Cell reports.
[32] P. Thompson,et al. Substrate specificity, processivity, and kinetic mechanism of protein arginine methyltransferase 5. , 2013, Biochemistry.
[33] Claudio Agostinelli,et al. Selective inhibition of protein arginine methyltransferase 5 blocks initiation and maintenance of B-cell transformation. , 2015, Blood.
[34] P. Thompson,et al. Autodeimination of protein arginine deiminase 4 alters protein-protein interactions but not activity. , 2011, Biochemistry.
[35] B. Vogelstein,et al. p53 mutations in human cancers. , 1991, Science.
[36] G. Rosen,et al. Mechanism of Superoxide Generation by Neuronal Nitric-oxide Synthase* , 1999, The Journal of Biological Chemistry.
[37] R. Braren,et al. The family of toxin‐related ecto‐ADP‐ribosyltransferases in humans and the mouse , 2002, Protein science : a publication of the Protein Society.
[38] Thomas W. Linsky,et al. Mechanistic similarity and diversity among the guanidine-modifying members of the pentein superfamily. , 2010, Biochimica et biophysica acta.
[39] A. D. Clark,et al. Crystal structures of arginine deiminase with covalent reaction intermediates; implications for catalytic mechanism. , 2004, Structure.
[40] Pojen P. Chen,et al. NETs Are a Source of Citrullinated Autoantigens and Stimulate Inflammatory Responses in Rheumatoid Arthritis , 2013, Science Translational Medicine.
[41] N. Martin,et al. Synthesis and evaluation of protein arginine N-methyltransferase inhibitors designed to simultaneously occupy both substrate binding sites. , 2015, Organic & biomolecular chemistry.
[42] Kürşad Turgay,et al. Global impact of protein arginine phosphorylation on the physiology of Bacillus subtilis , 2012, Proceedings of the National Academy of Sciences.
[43] S. Arandjelovic,et al. PAD4-Mediated Neutrophil Extracellular Trap Formation Is Not Required for Immunity against Influenza Infection , 2011, PloS one.
[44] C. Briand,et al. Structure of the mammalian NOS regulator dimethylarginine dimethylaminohydrolase: A basis for the design of specific inhibitors. , 2006, Structure.
[45] D. Boger,et al. Insights into the mechanism of streptonigrin-induced protein arginine deiminase inactivation. , 2014, Bioorganic & medicinal chemistry.
[46] S. Richard,et al. Arginine Methylation of the Histone H3 Tail Impedes Effector Binding* , 2008, Journal of Biological Chemistry.
[47] A. Varshavsky,et al. In vivo half-life of a protein is a function of its amino-terminal residue. , 1986, Science.
[48] Zhike Lu,et al. Identification of 67 Histone Marks and Histone Lysine Crotonylation as a New Type of Histone Modification , 2011, Cell.
[49] G. Dreyfuss,et al. SMN, the product of the spinal muscular atrophy gene, binds preferentially to dimethylarginine-containing protein targets. , 2001, Molecular cell.
[50] Xiangli Cui,et al. D-amino acid based protein arginine deiminase inhibitors: Synthesis, pharmacokinetics, and in cellulo efficacy. , 2012, ACS medicinal chemistry letters.
[51] K. Kish,et al. Structural basis for CARM1 inhibition by indole and pyrazole inhibitors. , 2011, The Biochemical journal.
[52] J. Hazes,et al. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. , 2000, Arthritis and rheumatism.
[53] Andrew J. Bannister,et al. Histone Methylation Dynamic or Static? , 2002, Cell.
[54] K. O. Elliston,et al. Chemogenetic Analysis of Human Protein Methyltransferases , 2011, Chemical biology & drug design.
[55] Yuan Luo,et al. Development and use of clickable activity based protein profiling agents for protein arginine deiminase 4. , 2011, ACS chemical biology.
[56] P. Thompson,et al. A FluoPol-ABPP PAD2 High-Throughput Screen Identifies the First Calcium Site Inhibitor Targeting the PADs , 2014, ACS chemical biology.
[57] Toshiyuki Shimizu,et al. Structural basis for Ca2+-induced activation of human PAD4 , 2004, Nature Structural &Molecular Biology.
[58] Michael J. Bolt,et al. Peptidylarginine deiminase 2-catalyzed histone H3 arginine 26 citrullination facilitates estrogen receptor α target gene activation , 2012, Proceedings of the National Academy of Sciences.
[59] Sharmistha Pal,et al. Protein Arginine Methyltransferase 5 Suppresses the Transcription of the RB Family of Tumor Suppressors in Leukemia and Lymphoma Cells , 2008, Molecular and Cellular Biology.
[60] M. Yamada,et al. Methylation of the guanidino group of arginine residues prevents citrullination by peptidylarginine deiminase IV , 2005, FEBS letters.
[61] A. Imbalzano,et al. Protein Arginine Methyltransferase 7 Regulates Cellular Response to DNA Damage by Methylating Promoter Histones H2A and H4 of the Polymerase δ Catalytic Subunit Gene, POLD1* , 2012, The Journal of Biological Chemistry.
[62] S. Clarke,et al. Mechanistic studies on transcriptional coactivator protein arginine methyltransferase 1. , 2011, Biochemistry.
[63] M. Yamada,et al. Deimination of histone H2A and H4 at arginine 3 in HL-60 granulocytes. , 2005, Biochemistry.
[64] Robert E Collins,et al. Structural and sequence motifs of protein (histone) methylation enzymes. , 2005, Annual review of biophysics and biomolecular structure.
[65] Yingming Zhao,et al. JMJD6 Is a Histone Arginine Demethylase , 2007, Science.
[66] J. Côté,et al. Alternatively spliced protein arginine methyltransferase 1 isoform PRMT1v2 promotes the survival and invasiveness of breast cancer cells , 2012, Cell cycle.
[67] Chuan Li,et al. Evolutionarily conserved protein arginine methyltransferases in non‐mammalian animal systems , 2012, The FEBS journal.
[68] J. Wong,et al. A Role for CARM1-Mediated Histone H3 Arginine Methylation in Protecting Histone Acetylation by Releasing Corepressors from Chromatin , 2012, PloS one.
[69] Xing Zhang,et al. Structure of the predominant protein arginine methyltransferase PRMT1 and analysis of its binding to substrate peptides. , 2003, Structure.
[70] Aiping Zhang,et al. Crystal structure of the human PRMT5:MEP50 complex , 2012, Proceedings of the National Academy of Sciences.
[71] A. Fukamizu,et al. Protein arginine methyltransferase 7 has a novel homodimer‐like structure formed by tandem repeats , 2014, FEBS letters.
[72] P. Thompson,et al. Substrate specificity and kinetic studies of PADs 1, 3, and 4 identify potent and selective inhibitors of protein arginine deiminase 3. , 2010, Biochemistry.
[73] J. Hodgin,et al. Peptidylarginine deiminase inhibition is immunomodulatory and vasculoprotective in murine lupus. , 2013, The Journal of clinical investigation.
[74] O. Acevedo,et al. A Remodeled Protein Arginine Methyltransferase 1 (PRMT1) Generates Symmetric Dimethylarginine* , 2014, The Journal of Biological Chemistry.
[75] M. Zernicka-Goetz,et al. Histone arginine methylation regulates pluripotency in the early mouse embryo , 2007, Nature.
[76] M. Hottiger. ADP‐ribosylation of histones by ARTD1: An additional module of the histone code? , 2011, FEBS letters.
[77] X. Zheng. DNase, ADAMTS13, and iPAD4: good for the heart. , 2014, Blood.
[78] M. V. van Boekel,et al. Autoantibody systems in rheumatoid arthritis: specificity, sensitivity and diagnostic value , 2001, Arthritis research.
[79] S. Richard,et al. Tudor Domains Bind Symmetrical Dimethylated Arginines* , 2005, Journal of Biological Chemistry.
[80] R. Frye,et al. Characterization of five human cDNAs with homology to the yeast SIR2 gene: Sir2-like proteins (sirtuins) metabolize NAD and may have protein ADP-ribosyltransferase activity. , 1999, Biochemical and biophysical research communications.
[81] Shen-Liang Chen,et al. The Coactivator-associated Arginine Methyltransferase Is Necessary for Muscle Differentiation , 2002, The Journal of Biological Chemistry.
[82] PRMT5 is Required for Human Embryonic Stem Cell Proliferation But Not Pluripotency , 2014, Stem Cell Reviews and Reports.
[83] Paul R Thompson,et al. Kinetic mechanism of protein arginine methyltransferase 1. , 2008, Biochemistry.
[84] B Tidor,et al. Arginine-mediated RNA recognition: the arginine fork , 1991, Science.
[85] A. Goffeau,et al. Cloning and functional analysis of the arginyl-tRNA-protein transferase gene ATE1 of Saccharomyces cerevisiae. , 1990, The Journal of biological chemistry.
[86] P. Thompson,et al. Synthesis and screening of a haloacetamidine containing library to identify PAD4 selective inhibitors. , 2012, ACS chemical biology.
[87] Guido Marcucci,et al. Genetic validation of the protein arginine methyltransferase PRMT5 as a candidate therapeutic target in glioblastoma. , 2014, Cancer research.
[88] I. Miyahara,et al. Structures of Argininosuccinate Synthetase in Enzyme-ATP Substrates and Enzyme-AMP Product Forms , 2003, Journal of Biological Chemistry.
[89] M. Waters,et al. Arginine methylation in a β-hairpin peptide: Implications for Arg-π interactions, ΔCp°, and the cold denatured state , 2006 .
[90] T. Richmond,et al. Crystal structure of the nucleosome core particle at 2.8 Å resolution , 1997, Nature.
[91] D. Wagner,et al. Neutrophil histone modification by peptidylarginine deiminase 4 is critical for deep vein thrombosis in mice , 2013, Proceedings of the National Academy of Sciences.
[92] Heather L. Rust,et al. A combinatorial approach to characterize the substrate specificity of protein arginine methyltransferase 1. , 2011, Molecular bioSystems.
[93] F. Mastronardi,et al. Peptidylarginine deiminase: a candidate factor in demyelinating disease , 2002, Journal of neurochemistry.
[94] M. Radic,et al. Deimination of linker histones links neutrophil extracellular trap release with autoantibodies in systemic autoimmunity , 2014, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[95] C. Sardet,et al. Coactivator-associated arginine methyltransferase 1 (CARM1) is a positive regulator of the Cyclin E1 gene , 2006, Proceedings of the National Academy of Sciences.
[96] C. Allis,et al. Translating the Histone Code , 2001, Science.
[97] W. Ellington,et al. Evolution and physiological roles of phosphagen systems. , 2001, Annual review of physiology.
[98] Sergio E. Wong,et al. Strengths of hydrogen bonds involving phosphorylated amino acid side chains. , 2007, Journal of the American Chemical Society.
[99] C. Allis,et al. Proteolytic processing of histone H3 in chromatin: a physiologically regulated event in tetrahymena micronuclei , 1980, Cell.
[100] A. Zychlinsky,et al. Neutrophil Extracellular Traps Kill Bacteria , 2004, Science.
[101] A. Yoshiki,et al. Human peptidylarginine deiminase type III: molecular cloning and nucleotide sequence of the cDNA, properties of the recombinant enzyme, and immunohistochemical localization in human skin. , 2000, The Journal of investigative dermatology.
[102] Jian Jin,et al. An allosteric inhibitor of protein arginine methyltransferase 3. , 2012, Structure.
[103] M. Machius,et al. Structural basis of histone demethylation by LSD1 revealed by suicide inactivation , 2007, Nature Structural &Molecular Biology.
[104] J. Côté,et al. The arginine methyltransferase CARM1 regulates the coupling of transcription and mRNA processing. , 2007, Molecular cell.
[105] Jinxiang Han,et al. Expression of peptidylarginine deiminase type 4 (PAD4) in various tumors , 2006, Molecular carcinogenesis.
[106] Wolfgang Knecht,et al. Structure of the Bacillus subtilis D-aminopeptidase DppA reveals a novel self-compartmentalizing protease , 2001, Nature Structural Biology.
[107] M. Mann,et al. Jmjd6 Catalyses Lysyl-Hydroxylation of U2AF65, a Protein Associated with RNA Splicing , 2009, Science.
[108] Jianping Lin,et al. Theoretical study of the mechanism of protein arginine deiminase 4 (PAD4) inhibition by F-amidine. , 2015, Journal of molecular graphics & modelling.
[109] A. Levine,et al. Surfing the p53 network , 2000, Nature.
[110] K. Elkon,et al. Type I IFN system in the development and manifestations of SLE , 2012, Current opinion in rheumatology.
[111] W. Sippl,et al. Acyl derivatives of p-aminosulfonamides and dapsone as new inhibitors of the arginine methyltransferase hPRMT1. , 2011, Bioorganic & medicinal chemistry.
[112] A. Ishigami,et al. Molecular Characterization of Peptidylarginine Deiminase in HL-60 Cells Induced by Retinoic Acid and 1α,25-Dihydroxyvitamin D3 * , 1999, The Journal of Biological Chemistry.
[113] Yang Shi,et al. Histone Demethylation Mediated by the Nuclear Amine Oxidase Homolog LSD1 , 2004, Cell.
[114] C. Jung,et al. Differential CARM1 expression in prostate and colorectal cancers , 2010, BMC Cancer.
[115] K. Nomura. Specificity and mode of action of the muscle-type protein-arginine deiminase. , 1992, Archives of biochemistry and biophysics.
[116] P. Vallance,et al. Structural insights into the hydrolysis of cellular nitric oxide synthase inhibitors by dimethylarginine dimethylaminohydrolase , 2001, Nature Structural Biology.
[117] Heike Brand,et al. Estrogen Receptor-α Directs Ordered, Cyclical, and Combinatorial Recruitment of Cofactors on a Natural Target Promoter , 2003, Cell.
[118] D. A. Dougherty,et al. The Cationminus signpi Interaction. , 1997, Chemical reviews.
[119] M. Bedford,et al. Protein arginine methyltransferases and cancer , 2012, Nature Reviews Cancer.
[120] Reinout Raijmakers,et al. Methylation of arginine residues interferes with citrullination by peptidylarginine deiminases in vitro. , 2007, Journal of molecular biology.
[121] Toshiyuki Shimizu,et al. Structural basis for histone N-terminal recognition by human peptidylarginine deiminase 4. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[122] Pamela A. Silver,et al. The structure and oligomerization of the yeast arginine methyltransferase, Hmt1 , 2000, Nature Structural Biology.
[123] C. D. Krause,et al. FBXO11/PRMT9, a new protein arginine methyltransferase, symmetrically dimethylates arginine residues. , 2006, Biochemical and biophysical research communications.
[124] P. Thompson,et al. Protein arginine deiminase 4: evidence for a reverse protonation mechanism. , 2007, Biochemistry.
[125] L. Pray. At the flick of a switch: epigenetic drugs. , 2008, Chemistry & biology.
[126] D. Higgins,et al. Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega , 2011, Molecular systems biology.
[127] Min Jae Lee,et al. RGS4 and RGS5 are in vivo substrates of the N-end rule pathway. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[128] C. Allis,et al. Covalent histone modifications — miswritten, misinterpreted and mis-erased in human cancers , 2010, Nature Reviews Cancer.
[129] S. Pang,et al. Pyrazole inhibitors of coactivator associated arginine methyltransferase 1 (CARM1). , 2008, Bioorganic & medicinal chemistry letters.
[130] Yusuke Nakamura,et al. Regulation of histone modification and chromatin structure by the p53–PADI4 pathway , 2012, Nature Communications.
[131] Robert A. Copeland,et al. Protein methyltransferases as a target class for drug discovery , 2009, Nature Reviews Drug Discovery.
[132] James E. Bray,et al. Crystal structures of histone demethylase JMJD2A reveal basis for substrate specificity , 2007, Nature.
[133] Steven Clarke,et al. PRMT5 (Janus Kinase-binding Protein 1) Catalyzes the Formation of Symmetric Dimethylarginine Residues in Proteins* , 2001, The Journal of Biological Chemistry.
[134] P. Thompson,et al. Protein arginine methyltransferase 5 catalyzes substrate dimethylation in a distributive fashion. , 2014, Biochemistry.
[135] C. Ackerley,et al. Inhibition of peptidyl-arginine deiminases reverses protein-hypercitrullination and disease in mouse models of multiple sclerosis , 2012, Disease Models & Mechanisms.
[136] W. Robinson,et al. N-α-Benzoyl-N5-(2-Chloro-1-Iminoethyl)-l-Ornithine Amide, a Protein Arginine Deiminase Inhibitor, Reduces the Severity of Murine Collagen-Induced Arthritis , 2011, The Journal of Immunology.
[137] Lang Li,et al. Aberrant expression of CARM1, a transcriptional coactivator of androgen receptor, in the development of prostate carcinoma and androgen‐independent status , 2004, Cancer.
[138] Sharmistha Pal,et al. Human SWI/SNF-Associated PRMT5 Methylates Histone H3 Arginine 8 and Negatively Regulates Expression of ST7 and NM23 Tumor Suppressor Genes , 2004, Molecular and Cellular Biology.
[139] C. Allis,et al. Histone arginine methylation and its dynamic regulation. , 2006, Frontiers in bioscience : a journal and virtual library.
[140] A. Monzingo,et al. Characterization of C‐Alkyl Amidines as Bioavailable Covalent Reversible Inhibitors of Human DDAH‐1 , 2011, ChemMedChem.
[141] E. Stone,et al. Inactivation of two diverse enzymes in the amidinotransferase superfamily by 2-chloroacetamidine: dimethylargininase and peptidylarginine deiminase. , 2005, Biochemistry.
[142] S. Clarke,et al. δ-N-Methylarginine Is a Novel Posttranslational Modification of Arginine Residues in Yeast Proteins* , 1998, The Journal of Biological Chemistry.
[143] Hugh Rosen,et al. Novel inhibitors for PRMT1 discovered by high-throughput screening using activity-based fluorescence polarization. , 2012, ACS chemical biology.
[144] Joan M Hevel,et al. Substrate profiling of PRMT1 reveals amino acid sequences that extend beyond the "RGG" paradigm. , 2008, Biochemistry.
[145] Sandra K. Wittmann,et al. PADI4 acts as a coactivator of Tal1 by counteracting repressive histone arginine methylation , 2014, Nature Communications.
[146] B. Garcia,et al. Methylation of H2AR29 is a novel repressive PRMT6 target , 2011, Epigenetics & Chromatin.
[147] M. Moscarello,et al. A novel microtubule independent effect of paclitaxel: the inhibition of peptidylarginine deiminase from bovine brain. , 1998, Biochimica et biophysica acta.
[148] Cheng Luo,et al. Theoretical Insights into Catalytic Mechanism of Protein Arginine Methyltransferase 1 , 2013, PloS one.
[149] P. Thompson,et al. Genome-Wide Analysis Reveals PADI4 Cooperates with Elk-1 to Activate c-Fos Expression in Breast Cancer Cells , 2011, PLoS genetics.
[150] Yuan Luo,et al. Inhibitors and inactivators of protein arginine deiminase 4: functional and structural characterization. , 2006, Biochemistry.
[151] P. Thompson,et al. Activity-based protein profiling of protein arginine methyltransferase 1. , 2011, ACS chemical biology.
[152] H. Bull,et al. Erosive Rheumatoid Arthritis Is Associated with Antibodies That Activate PAD4 by Increasing Calcium Sensitivity , 2013, Science Translational Medicine.
[153] D. Wagner,et al. Thrombosis: tangled up in NETs. , 2014, Blood.
[154] P. Thompson,et al. Targeting the arginine phosphatase YwlE with a catalytic redox-based inhibitor. , 2013, ACS chemical biology.
[155] Ulf Reimer,et al. Histone H2A and H4 N-terminal Tails Are Positioned by the MEP50 WD Repeat Protein for Efficient Methylation by the PRMT5 Arginine Methyltransferase* , 2015, The Journal of Biological Chemistry.
[156] Jorng-Tzong Horng,et al. Incorporating structural characteristics for identification of protein methylation sites , 2009, J. Comput. Chem..
[157] J. Karn,et al. Distribution of NG, NG,-dimethylarginine in nuclear protein fractions. , 1977, Biochemical and biophysical research communications.
[158] N. L. La Thangue,et al. HDAC inhibitors in cancer biology: emerging mechanisms and clinical applications , 2012, Immunology and cell biology.
[159] J. Yates,et al. PRMT5 modulates the metabolic response to fasting signals , 2013, Proceedings of the National Academy of Sciences.
[160] S. Emamzadah,et al. Crystal Structure of a Multidomain Human p53 Tetramer Bound to the Natural CDKN1A (p21) p53-Response Element , 2011, Molecular Cancer Research.
[161] P. Tsao,et al. Asymmetrical Dimethylarginine in Renal Disease: Limits of Variation or Variation Limits? , 2007, American Journal of Nephrology.
[162] M. Hu,et al. Specific protein methylation defects and gene expression perturbations in coactivator-associated arginine methyltransferase 1-deficient mice , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[163] Robert L Moritz,et al. PRMT5-mediated methylation of histone H4R3 recruits DNMT3A, coupling histone and DNA methylation in gene silencing , 2009, Nature Structural &Molecular Biology.
[164] Steven M. Johnson,et al. Determinants of nucleosome organization in primary human cells , 2011, Nature.
[165] Randall W King,et al. Small Molecule Regulators of Protein Arginine Methyltransferases* , 2004, Journal of Biological Chemistry.
[166] Tony Pawson,et al. Deciphering arginine methylation: Tudor tells the tale , 2011, Nature Reviews Molecular Cell Biology.
[167] R. Seifert,et al. Acylguanidines as bioisosteres of guanidines: NG-acylated imidazolylpropylguanidines, a new class of histamine H2 receptor agonists. , 2008, Journal of medicinal chemistry.
[168] Michael R. Lindberg,et al. PAD4 is essential for antibacterial innate immunity mediated by neutrophil extracellular traps , 2010, The Journal of experimental medicine.
[169] Terrence J Sejnowski,et al. Calcium Green FlAsH as a genetically targeted small-molecule calcium indicator. , 2007, Nature chemical biology.
[170] P. Thompson,et al. Mechanistic Studies of Protein Arginine Deiminase 2: Evidence for a Substrate-Assisted Mechanism , 2014, Biochemistry.
[171] P. Thompson,et al. Kinetic characterization of protein arginine deiminase 4: a transcriptional corepressor implicated in the onset and progression of rheumatoid arthritis. , 2005, Biochemistry.
[172] C. A. Lewis,et al. The nonenzymatic decomposition of guanidines and amidines. , 2014, Journal of the American Chemical Society.
[173] P. Thompson,et al. Protein arginine deiminase 4: a target for an epigenetic cancer therapy , 2011, Cellular and Molecular Life Sciences.
[174] T. Miranda,et al. PRMT7 Is a Member of the Protein Arginine Methyltransferase Family with a Distinct Substrate Specificity* , 2004, Journal of Biological Chemistry.
[175] David M. Wilson,et al. Inhibition of PAD4 activity is sufficient to disrupt mouse and human NET formation , 2015, Nature chemical biology.
[176] Yuan Luo,et al. The development of N-α-(2-carboxyl)benzoyl-N(5)-(2-fluoro-1-iminoethyl)-l-ornithine amide (o-F-amidine) and N-α-(2-carboxyl)benzoyl-N(5)-(2-chloro-1-iminoethyl)-l-ornithine amide (o-Cl-amidine) as second generation protein arginine deiminase (PAD) inhibitors. , 2011, Journal of medicinal chemistry.
[177] M. Gross,et al. Protein Arginine Deiminase 2 Binds Calcium in an Ordered Fashion: Implications for Inhibitor Design , 2015, ACS chemical biology.
[178] S. Smith,et al. The world according to PARP. , 2001, Trends in biochemical sciences.
[179] J. Hevel,et al. Substrate-induced control of product formation by protein arginine methyltransferase 1. , 2013, Biochemistry.
[180] S. Blethen. Kinetic properties of the arginine kinase isoenzymes of Limulus polyphemus. , 1972, Archives of biochemistry and biophysics.
[181] E. Wahle,et al. Peptide backbone conformation affects the substrate preference of protein arginine methyltransferase I. , 2012, Biochemistry.
[182] M. Jansson,et al. Arginine methylation regulates the p53 response , 2008, Nature Cell Biology.
[183] C. Langford,et al. CARM1 Is Required in Embryonic Stem Cells to Maintain Pluripotency and Resist Differentiation , 2009, Stem cells.
[184] Yuan Luo,et al. Profiling Protein Arginine Deiminase 4 (PAD4): a novel screen to identify PAD4 inhibitors. , 2008, Bioorganic & medicinal chemistry.
[185] Yanming Wang,et al. Peptidylarginine deiminases in citrullination, gene regulation, health and pathogenesis. , 2013, Biochimica et biophysica acta.
[186] P. Thompson,et al. Kinetic Mechanism of Protein Arginine Methyltransferase 6 (PRMT6)* , 2012, The Journal of Biological Chemistry.
[187] Yusuke Nakamura,et al. Regulation of protein Citrullination through p53/PADI4 network in DNA damage response. , 2009, Cancer research.
[188] A. Silman,et al. UvA-DARE (Digital Academic Repository) 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative Aletaha, , 2010 .
[189] F. Young. Biochemistry , 1955, The Indian Medical Gazette.
[190] Xin Wu,et al. Cellular localization of protein arginine methyltransferase-5 correlates with grade of lung tumors , 2013, Diagnostic Pathology.
[191] K. Mechtler,et al. McsB Is a Protein Arginine Kinase That Phosphorylates and Inhibits the Heat-Shock Regulator CtsR , 2009, Science.
[192] Jing Hu,et al. Anticancer Peptidylarginine Deiminase (PAD) Inhibitors Regulate the Autophagy Flux and the Mammalian Target of Rapamycin Complex 1 Activity* , 2012, The Journal of Biological Chemistry.
[193] Andrew J. Bannister,et al. Regulation of chromatin by histone modifications , 2011, Cell Research.
[194] C. Allis,et al. The language of covalent histone modifications , 2000, Nature.
[195] L. Burzio,et al. ADP ribosylation of rat liver nucleosomal core histones. , 1979, The Journal of biological chemistry.
[196] C. Wolberger,et al. Structure-based Mechanism of ADP-ribosylation by Sirtuins , 2009, The Journal of Biological Chemistry.
[197] M. Yamada,et al. Nuclear Localization of Peptidylarginine Deiminase V and Histone Deimination in Granulocytes* , 2002, The Journal of Biological Chemistry.
[198] A. Vaughan,et al. Stimulation of a Ca2+-Calmodulin-activated Histone 3 Arginine Kinase in Quiescent Rat Heart Endothelial Cells Compared to Actively Dividing Cells (*) , 1995, The Journal of Biological Chemistry.
[199] R. Lehmann,et al. Structural basis for methylarginine-dependent recognition of Aubergine by Tudor. , 2010, Genes & development.
[200] M. Radic,et al. Histone Deimination As a Response to Inflammatory Stimuli in Neutrophils1 , 2008, The Journal of Immunology.
[201] G. Golderer,et al. ADP-ribosylation of core histones and their acetylated subspecies. , 1991, The Biochemical journal.
[202] A. Ishigami,et al. Subcellular Localization of Peptidylarginine Deiminase 2 and Citrullinated Proteins in Brains of Scrapie-Infected Mice: Nuclear Localization of PAD2 and Membrane Fraction-Enriched Citrullinated Proteins , 2011, Journal of neuropathology and experimental neurology.
[203] K. Mechtler,et al. Studying the fragmentation behavior of peptides with arginine phosphorylation and its influence on phospho‐site localization , 2013, Proteomics.
[204] P. W. Codding,et al. Structural studies of duck delta2 crystallin mutants provide insight into the role of Thr161 and the 280s loop in catalysis. , 2004, The Biochemical journal.
[205] M. Stallcup,et al. A Chloroacetamidine‐Based Inactivator of Protein Arginine Methyltransferase 1: Design, Synthesis, and In Vitro and In Vivo Evaluation , 2010, Chembiochem : a European journal of chemical biology.
[206] C. Supuran,et al. Novel small molecule protein arginine deiminase 4 (PAD4) inhibitors. , 2013, Bioorganic & medicinal chemistry letters.
[207] A. Suzuki,et al. Citrullination by Peptidylarginine Deiminase in Rheumatoid Arthritis , 2007, Annals of the New York Academy of Sciences.
[208] Y. Wolf,et al. Global Analysis of Posttranslational Protein Arginylation , 2007, PLoS biology.
[209] Xing Zhang,et al. Protein arginine methyltransferase 1: positively charged residues in substrate peptides distal to the site of methylation are important for substrate binding and catalysis. , 2007, Biochemistry.
[210] P. Thompson,et al. Haloacetamidine‐Based Inactivators of Protein Arginine Deiminase 4 (PAD4): Evidence that General Acid Catalysis Promotes Efficient Inactivation , 2010, Chembiochem : a European journal of chemical biology.
[211] S. Li,et al. Superbinder SH2 Domains Act as Antagonists of Cell Signaling , 2012, Science Signaling.
[212] W. Warburton,et al. 549. The basic strengths of methylated guanidines , 1951 .
[213] M. Esteller. Epigenetics in cancer. , 2008, The New England journal of medicine.
[214] Yuan Luo,et al. Regulation of p53 Target Gene Expression by Peptidylarginine Deiminase 4 , 2008, Molecular and Cellular Biology.
[215] P. Thompson,et al. Protein arginine deiminase 4 (PAD4): Current understanding and future therapeutic potential. , 2009, Current opinion in drug discovery & development.
[216] S. Khorasanizadeh. The Nucleosome From Genomic Organization to Genomic Regulation , 2004, Cell.
[217] Mark T Bedford,et al. Arginine methyltransferase CARM1 is a promoter‐specific regulator of NF‐κB‐dependent gene expression , 2005, The EMBO journal.
[218] R. Cole,et al. Autocitrullination of human peptidyl arginine deiminase type 4 regulates protein citrullination during cell activation. , 2010, Arthritis and rheumatism.
[219] P. Thompson,et al. Chemical and biological methods to detect post‐translational modifications of arginine , 2014, Biopolymers.
[220] Nicholas M. Luscombe,et al. Amino acid?base interactions: a three-dimensional analysis of protein?DNA interactions at an atomic level , 2001, Nucleic Acids Res..
[221] J. Wurtz,et al. Structural insight into arginine methylation by the mouse protein arginine methyltransferase 7: a zinc finger freezes the mimic of the dimeric state into a single active site. , 2014, Acta crystallographica. Section D, Biological crystallography.
[222] T. Kumarevel,et al. Crystal structure of the nucleosome core particle , 2015 .
[223] Michael J. Guertin,et al. Targeted H3R26 Deimination Specifically Facilitates Estrogen Receptor Binding by Modifying Nucleosome Structure , 2014, PLoS genetics.
[224] Hongtao Yu,et al. Structural insights into histone lysine demethylation. , 2010, Current opinion in structural biology.
[225] S. Morris. Regulation of enzymes of the urea cycle and arginine metabolism. , 2002, Annual review of nutrition.
[226] D. Notterman,et al. The p53 tumor suppressor gene. , 1994, The Journal of laboratory and clinical medicine.
[227] C. Muchardt,et al. Citrullination of Histone H3 Interferes with HP1-Mediated Transcriptional Repression , 2012, PLoS genetics.
[228] M. S. Chapman,et al. The Putative Catalytic Bases Have, at Most, an Accessory Role in the Mechanism of Arginine Kinase* , 2003, Journal of Biological Chemistry.
[229] S. Rajski,et al. Design, Synthesis, and Preliminary Biological Evaluation of a DNA Methyltransferase‐Directed Alkylating Agent , 2006, Chembiochem : a European journal of chemical biology.
[230] Deepak Poudyal,et al. Suppression of colitis in mice by Cl-amidine: a novel peptidylarginine deiminase inhibitor. , 2011, American journal of physiology. Gastrointestinal and liver physiology.
[231] S. Clarke,et al. Protein arginine methylation in mammals: who, what, and why. , 2009, Molecular cell.
[232] J. Yates,et al. Arginylation and methylation double up to regulate nuclear proteins and nuclear architecture in vivo. , 2011, Chemistry & biology.
[233] Jing Zhong,et al. Identification and expression analysis of a novel transcript of the human PRMT2 gene resulted from alternative polyadenylation in breast cancer. , 2011, Gene.
[234] Tony Kouzarides,et al. SnapShot: Histone-Modifying Enzymes , 2007, Cell.
[235] M. Feldmann,et al. Autoimmunity to specific citrullinated proteins gives the first clues to the etiology of rheumatoid arthritis , 2010, Immunological reviews.
[236] Sharmistha Pal,et al. mSin3A/Histone Deacetylase 2- and PRMT5-Containing Brg1 Complex Is Involved in Transcriptional Repression of the Myc Target Gene cad , 2003, Molecular and Cellular Biology.
[237] W. Kidwell,et al. Properties of the complex between histone H1 and poly(ADP-ribose synthesised in HeLa cell nuclei. , 1977, European journal of biochemistry.
[238] S. Liang,et al. TDRD3 is an effector molecule for arginine-methylated histone marks. , 2010, Molecular cell.
[239] J. Bilbao,et al. Acute multiple sclerosis (marburg type) is associated with developmentally immature myelin basic protein , 1996, Annals of neurology.
[240] G. Muscat,et al. CARM1/PRMT4 is necessary for the glycogen gene expression programme in skeletal muscle cells. , 2012, The Biochemical journal.
[241] Xavier Robert,et al. Deciphering key features in protein structures with the new ENDscript server , 2014, Nucleic Acids Res..
[242] Ronald W. Davis,et al. A high-resolution atlas of nucleosome occupancy in yeast , 2007, Nature Genetics.
[243] L. A. Bush,et al. ePAD, an oocyte and early embryo-abundant peptidylarginine deiminase-like protein that localizes to egg cytoplasmic sheets. , 2003, Developmental biology.
[244] Steven J Brown,et al. A fluopol-ABPP HTS assay to identify PAD inhibitors. , 2010, Chemical communications.
[245] Q. Gong,et al. Structural determinants for the strict monomethylation activity by trypanosoma brucei protein arginine methyltransferase 7. , 2014, Structure.
[246] Dino Moras,et al. Functional insights from structures of coactivator‐associated arginine methyltransferase 1 domains , 2007, The EMBO journal.
[247] Benjamin A Garcia,et al. Proteomic characterization of novel histone post-translational modifications , 2013, Epigenetics & Chromatin.
[248] C. D. Krause,et al. Protein arginine methyltransferases: evolution and assessment of their pharmacological and therapeutic potential. , 2007, Pharmacology & therapeutics.
[249] Ted M. Lakowski,et al. A Kinetic Study of Human Protein Arginine N-Methyltransferase 6 Reveals a Distributive Mechanism* , 2008, Journal of Biological Chemistry.
[250] Ailan Guo,et al. PRMT9 is a Type II methyltransferase that methylates the splicing factor SAP145 , 2015, Nature Communications.
[251] C. Ackerley,et al. Peptidylarginine deiminase 2 ( PAD 2 ) overexpression in transgenic mice leads to myelin loss in the central nervous system , 2022 .
[252] Steven Clarke,et al. Human PAD4 Regulates Histone Arginine Methylation Levels via Demethylimination , 2004, Science.
[253] P. Li,et al. Coordination of PAD4 and HDAC2 in the regulation of p53-target gene expression , 2010, Oncogene.
[254] A. Imbalzano,et al. Protein arginine methyltransferase 5 (Prmt5) promotes gene expression of peroxisome proliferator-activated receptor γ2 (PPARγ2) and its target genes during adipogenesis. , 2012, Molecular endocrinology.
[255] Discovery of a structurally novel, drug-like and potent inhibitor of peptidylarginine deiminase , 2013 .
[256] B. Wang,et al. Discovery and mechanistic study of a class of protein arginine methylation inhibitors. , 2010, Journal of medicinal chemistry.
[257] Steven R. Shave,et al. Discovery of a new class of inhibitors for the protein arginine deiminase type 4 (PAD4) by structure-based virtual screening , 2012, BMC Bioinformatics.
[258] G. Chang,et al. Chemical mechanism of the endogenous argininosuccinate lyase activity of duck lens delta2-crystallin. , 1998, The Biochemical journal.
[259] E. Kremmer,et al. Arginine methylation next to the PY‐NLS modulates Transportin binding and nuclear import of FUS , 2012, The EMBO journal.
[260] K. Mizuguchi,et al. A novel superfamily of enzymes that catalyze the modification of guanidino groups. , 2001, Trends in biochemical sciences.
[261] Biao-yang Lin,et al. A Novel Histone H4 Arginine 3 Methylation-sensitive Histone H4 Binding Activity and Transcriptional Regulatory Function for Signal Recognition Particle Subunits SRP68 and SRP72* , 2012, The Journal of Biological Chemistry.
[262] Bryan J. Venters,et al. Histone Arg Modifications and p53 Regulate the Expression of OKL38, a Mediator of Apoptosis* , 2008, Journal of Biological Chemistry.
[263] J. Hodgin,et al. Peptidylarginine deiminase inhibition disrupts NET formation and protects against kidney, skin and vascular disease in lupus-prone MRL/lpr mice , 2014, Annals of the rheumatic diseases.
[264] C. Allis,et al. Methylation of lysine 4 on histone H3: intricacy of writing and reading a single epigenetic mark. , 2007, Molecular cell.
[265] Timothy L Bailey,et al. Defining the RGG/RG motif. , 2013, Molecular cell.
[266] H. Ruley,et al. Arginine N-Methyltransferase 1 Is Required for Early Postimplantation Mouse Development, but Cells Deficient in the Enzyme Are Viable , 2000, Molecular and Cellular Biology.
[267] S. Clarke,et al. The Novel Human Protein Arginine N-Methyltransferase PRMT6 Is a Nuclear Enzyme Displaying Unique Substrate Specificity* , 2002, The Journal of Biological Chemistry.
[268] Kerstin Neubert,et al. DRE-1: an evolutionarily conserved F box protein that regulates C. elegans developmental age. , 2007, Developmental cell.
[269] J. G. Hirsch. BACTERICIDAL ACTION OF HISTONE , 1958, The Journal of experimental medicine.
[270] David Baker,et al. Quantitative reactivity profiling predicts functional cysteines in proteomes , 2010, Nature.
[271] Zongyang Lv,et al. Structural insights into protein arginine symmetric dimethylation by PRMT5 , 2011, Proceedings of the National Academy of Sciences.
[272] Xiaojiang Xu,et al. Application of machine learning methods to histone methylation ChIP-Seq data reveals H4R3me2 globally represses gene expression , 2010, BMC Bioinformatics.
[273] András Falus,et al. Citrullination: a posttranslational modification in health and disease. , 2006, The international journal of biochemistry & cell biology.
[274] A. Scorilas,et al. Clinical evaluation of PRMT1 gene expression in breast cancer , 2011, Tumor Biology.
[275] Wei Hong,et al. Toward the development of potent and selective bisubstrate inhibitors of protein arginine methyltransferases. , 2010, Bioorganic & medicinal chemistry letters.
[276] E. Stone,et al. Substrate-assisted cysteine deprotonation in the mechanism of dimethylargininase (DDAH) from Pseudomonas aeruginosa. , 2006, Biochemistry.
[277] B. Wakim,et al. Ca(2+)-calmodulin-dependent phosphorylation of arginine in histone 3 by a nuclear kinase from mouse leukemia cells. , 1994, The Journal of biological chemistry.
[278] J. Cooke,et al. Asymmetric dimethylarginine (ADMA): a key regulator of nitric oxide synthase. , 2003, Atherosclerosis. Supplements.
[279] M. S. Chapman,et al. Transition state structure of arginine kinase: implications for catalysis of bimolecular reactions. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[280] P. Trojer,et al. A novel arginine methyltransferase inhibitor with cellular activity. , 2007, Bioorganic & medicinal chemistry letters.
[281] R. Blumenthal,et al. Many paths to methyltransfer: a chronicle of convergence. , 2003, Trends in biochemical sciences.
[282] I. Treilleux,et al. Regulation of estrogen rapid signaling through arginine methylation by PRMT1. , 2008, Molecular cell.
[283] K. Sugawara,et al. Properties of peptidylarginine deiminase from the epidermis of newborn rats. , 1981, Journal of biochemistry.
[284] Ted M. Lakowski,et al. Peptidic Partial Bisubstrates as Inhibitors of the Protein Arginine N‐Methyltransferases , 2011, Chembiochem : a European journal of chemical biology.
[285] Troy E. Sandberg,et al. Human Protein Arginine Methyltransferase 7 (PRMT7) Is a Type III Enzyme Forming ω-NG-Monomethylated Arginine Residues* , 2012, The Journal of Biological Chemistry.
[286] K. Kehn-Hall,et al. Methylation of the Tumor Suppressor Protein, BRCA1, Influences Its Transcriptional Cofactor Function , 2010, PLoS ONE.
[287] Jens Böse,et al. Analysis of Jmjd6 Cellular Localization and Testing for Its Involvement in Histone Demethylation , 2010, PloS one.
[288] Kun Qian,et al. Diamidine Compounds for Selective Inhibition of Protein Arginine Methyltransferase 1 , 2014, Journal of medicinal chemistry.
[289] Heather L. Rust. Decoding PRMT1: Studies On the Catalytic Mechanism, Regulation, Inhibition, and Crosstalk of PRMT1-Dependent Methylation , 2013 .
[290] D. Aswad,et al. Regulation of transcription by a protein methyltransferase. , 1999, Science.
[291] A. Varshavsky,et al. The N-end rule pathway as a nitric oxide sensor controlling the levels of multiple regulators , 2005, Nature.
[292] Jun Li,et al. CARM1 is an important determinant of ERα-dependent breast cancer cell differentiation and proliferation in breast cancer cells. , 2011, Cancer research.
[293] S. Khorasanizadeh,et al. Recognition of trimethyllysine by a chromodomain is not driven by the hydrophobic effect , 2007, Proceedings of the National Academy of Sciences.
[294] Xiaodong Cheng,et al. Crystal structure of the conserved core of protein arginine methyltransferase PRMT3 , 2000, The EMBO journal.
[295] Guang-Yaw Liu,et al. Functional Role of Dimerization of Human Peptidylarginine Deiminase 4 (PAD4) , 2011, PloS one.
[296] Paul Tempst,et al. Histone Deimination Antagonizes Arginine Methylation , 2004, Cell.
[297] A. Chumanevich,et al. Seeing citrulline: development of a phenylglyoxal-based probe to visualize protein citrullination. , 2012, Journal of the American Chemical Society.
[298] P. Trojer,et al. Target-based approach to inhibitors of histone arginine methyltransferases. , 2007, Journal of medicinal chemistry.
[299] Mark T Bedford,et al. Arginine methylation an emerging regulator of protein function. , 2005, Molecular cell.
[300] E. Vossenaar,et al. PAD, a growing family of citrullinating enzymes: genes, features and involvement in disease , 2003, BioEssays : news and reviews in molecular, cellular and developmental biology.
[301] M. Bedford,et al. Histone arginine methylation , 2011, FEBS letters.
[302] O. Griffith,et al. Identification of PADI2 as a potential breast cancer biomarker and therapeutic target , 2012, BMC Cancer.
[303] C. Allis,et al. Methylation of Histone H4 at Arginine 3 Facilitating Transcriptional Activation by Nuclear Hormone Receptor , 2001, Science.
[304] Thomas W. Linsky,et al. Guanidine-modifying enzymes in the pentein superfamily , 2010 .
[305] H R Herschman,et al. PRMT1 Is the Predominant Type I Protein Arginine Methyltransferase in Mammalian Cells* , 2000, The Journal of Biological Chemistry.
[306] M. Cleary,et al. Protein arginine-methyltransferase-dependent oncogenesis , 2007, Nature Cell Biology.
[307] H. Erdjument-Bromage,et al. Histone demethylation by a family of JmjC domain-containing proteins , 2006, Nature.
[308] Yuan Luo,et al. A fluoroacetamidine-based inactivator of protein arginine deiminase 4: design, synthesis, and in vitro and in vivo evaluation. , 2006, Journal of the American Chemical Society.
[309] Yusuke Nakamura,et al. Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis , 2003, Nature Genetics.
[310] H. Kessler. Detection of Hindered Rotation and Inversion by NMR Spectroscopy , 1970 .
[311] P. Thompson,et al. Peptidylarginine Deiminase Inhibition Reduces Vascular Damage and Modulates Innate Immune Responses in Murine Models of Atherosclerosis , 2014, Circulation research.
[312] D. Fessas,et al. Structural basis for dimethylarginine recognition by the Tudor domains of human SMN and SPF30 proteins , 2011, Nature Structural &Molecular Biology.
[313] G. Stark,et al. PRMT5 dimethylates R30 of the p65 subunit to activate NF-κB , 2013, Proceedings of the National Academy of Sciences.
[314] J. Moss,et al. Molecular and immunological characterization of ADP-ribosylarginine hydrolases. , 1992, The Journal of biological chemistry.